According to the company, effective January 1, 2025, cyclosporine ophthalmic solution 0.1% (Vevye) will be included on key ...

More recently, Caremark, a PBM owned by CVS, agreed to pay the state $45 million amid allegations it failed to pass along ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their prescriptions on a hot summer day, some stopped in for coffee, ice cream, homemade cake ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

(Reuters) - CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, ...

who was president of CVS' pharmacy benefits manager subsidiary, Caremark. Even as Nelson's hiring was made public, CVS Health ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...

CVS Health reported $87 million in net income in the third quarter, down from nearly $2.3 billion year over year. Total revenue in Q3 was $95.4 billion, up 6.3% from the same time period last year.